EF
REGN icon

Empowered Funds’s Regeneron Pharmaceuticals REGN Stock Holding History

Empowered Funds’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2M Buy
33,963
+18,345
+117% +$12.5M 0.11% 181
2026
Q1 		$12.1M Sell
15,618
-17,442
-53% -$13.4M 0.08% 302
2025
Q4 		$25.5M Sell
33,060
-2,027
-6% -$1.38M 0.43% 42
2025
Q3 		$19.7M Buy
35,087
+25,687
+273% +$14.5M 0.2% 89
2025
Q2 		$4.93M Buy
9,400
+7,207
+329% +$4.02M 0.06% 446
2025
Q1 		$1.39M Sell
2,193
-10,817
-83% -$7.44M 0.02% 889
2024
Q4 		$9.27M Buy
13,010
+11,358
+688% +$9.53M 0.14% 172
2024
Q3 		$1.74M Buy
1,652
+109
+7% +$121K 0.03% 720
2024
Q2 		$1.62M Buy
1,543
+190
+14% +$184K 0.03% 683
2024
Q1 		$1.3M Buy
1,353
+347
+34% +$330K 0.02% 762
2023
Q4 		$884K Buy
1,006
+123
+14% +$101K 0.02% 812
2023
Q3 		$727K Buy
883
+189
+27% +$149K 0.02% 780
2023
Q2 		$499K Buy
694
+243
+54% +$187K 0.02% 822
2023
Q1 		$371K Buy
+451
New +$340K 0.02% 430
2022
Q3 		– Sell
-7,006
Closed -$4.14M – 370
2022
Q2 		$4.14M Buy
7,006
+440
+7% +$286K 0.53% 54
2022
Q1 		$4.59M Sell
6,566
-1,038
-14% -$657K 0.5% 57
2021
Q4 		$4.8M Buy
+7,604
New +$4.68M 0.54% 71
2020
Q3 		– Sell
-2,268
Closed -$1.41M – 143
2020
Q2 		$1.41M Buy
+2,268
New +$1.29M 0.55% 61

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Empowered Funds's REGN Position: Q2 2026 in Review

Empowered Funds increased its Regeneron Pharmaceuticals (REGN) stake by 117% in Q2 2026, buying an estimated $12.5M and bringing the position to 33,963 shares worth $21.2M. The position accounts for 0.11% of the portfolio, ranked #181.

Empowered Funds first reported a position in REGN in Q2 2020 and has held it in 18 quarters since. The position peaked at $25.5M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Empowered Funds held 33,963 shares of Regeneron Pharmaceuticals worth $21.2M as of Q2 2026.
  • Empowered Funds bought 18,345 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.5M.
  • Regeneron Pharmaceuticals made up 0.11% of Empowered Funds's portfolio in Q2 2026, its #181 holding.
  • Empowered Funds first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • Empowered Funds's Regeneron Pharmaceuticals position peaked at $25.5M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.